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Voluntary exercise protects against
methamphetamine-induced oxidative stress in
brain microvasculature and disruption of the
blood–brain barrier
Michal Toborek1*, Melissa J Seelbach2, Cetewayo S Rashid3, Ibolya E András1, Lei Chen4, Minseon Park1
and Karyn A Esser5
Abstract
Background: There is no effective therapeutic intervention developed targeting cerebrovascular toxicity of drugs of
abuse, including methamphetamine (METH). We hypothesize that exercise protects against METH-induced
disruption of the blood–brain barrier (BBB) by enhancing the antioxidant capacity of cerebral microvessels and
modulating caveolae-associated signaling. Mice were subjected to voluntary wheel running for 5 weeks resembling
the voluntary pattern of human exercise, followed by injection with METH (10 mg/kg). The frequency, duration, and
intensity of each running session were monitored for each mouse via a direct data link to a computer and the
running data are analyzed by Clock lab™ Analysis software. Controls included mice sedentary that did not have
access to running wheels and/or injections with saline.
Results: METH induced oxidative stress in brain microvessels, resulting in up regulation of caveolae-associated
NAD(P)H oxidase subunits, and phosphorylation of mitochondrial protein 66Shc. Treatment with METH disrupted
also the expression and colocalization of tight junction proteins. Importantly, exercise markedly attenuated these
effects and protected against METH-induced disruption of the BBB integrity.
Conclusions: The obtained results indicate that exercise is an important modifiable behavioral factor that can
protect against METH-induced cerebrovascular toxicity. These findings may provide new strategies in preventing
the toxicity of drug of abuse.
Keywords: Methamphetamine, Drug abuse, Exercise, Blood-brain, Oxidative stress, Tight junctions
Background
Methamphetamine (METH) is an abused drug with over
35 million users worldwide. It produces a rapid, pleasur-
able rush followed by euphoria, heightened attention,
and increased energy. It was estimated that 10.4 million
people 12 or older (i.e., 4.3% of the population) have
tried methamphetamine at some time in their lives in
the US (http://www.drugabuse.gov). From 1995 to 2005,
admissions for primary abuse of methamphetamine/
amphetamine (METH/AMPH) increased in the US from 4
to 9%. Additional 4% of all substance abuse admissions
were for secondary or tertiary METH/AMPH abuse. In-
deed, 66% of primary METH/AMPH abusers reported
the use of other substances, including marijuana (41%),
alcohol (34%), and cocaine (10%) [1]. METH abuse is
three times higher in rural areas than in large cities [2].
Most METH users are white men 18 to 25 years of age;
however the highest usage rates have been found in na-
tive Hawaiians, persons of more than one race, Native
Americans, and men who have sex with men. Treatment
of METH abuse includes cognitive behavior therapy and
contingency management, although relapse rates remain
high for chronic METH abusers [3].
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METH abuse results in a long-term impairment of vascu-
lar functions that remain compromised even in abstinent
METH users [4]. Several toxic effects of METH, such as
myocardial infarction, stroke, and cardiomyopathy, are dir-
ectly related to vascular or cerebrovascular dysfunction. In
addition, the disruption of the blood–brain barrier (BBB)
has been established as one of the most prominent events of
METH toxicity [5-10]. The most significant METH-induced
alterations of the BBB occur in the cortex, followed by
the hippocampus [8]. These changes are correlated with
neurodegeneration, perineuronal and perivascular edema,
and expansion of the cortex [8,11]. Mechanistically, several
aspects of METH-induced toxicity are linked to production
of reactive oxygen species and induction of oxidative stress
[7,9,10,12].
In the present study, we evaluated the effects of volun-
tary exercise on METH-induced cerebrovascular tox-
icity. Exercise is a modifiable behavioral factor which
can produce several beneficial effects, including im-
proved cardiac functions and musculoskeletal health
[13]. Compelling evidence demonstrates the efficacy of
exercise in reduction of morbidity associated with car-
diovascular disease, obesity, and diabetes, as well as in
cancer prevention. It is recognized that exercise can
affect oxidative metabolism. For example, an aerobic
physical activity program induced antioxidant enzyme
activities, elevated resistance to oxidation of low density
lipoproteins (LDL), and decreased levels of oxidized LDL
in young and elderly patients with various forms of vas-
cular diseases [14]. In addition, plasma antioxidant levels
are correlated with physical performance [15]. Exercise
is also known to decrease levels of inflammatory media-
tors [16].
To date there is no effective therapy available to protect
against METH toxicity. Therefore, the aim of the present
study was to evaluate the neurobiological effects of exercise
on cerebrovascular toxicity of METH and, more specifically,
METH-induced disruption of the BBB and induction of
neuroinflammatory responses in the brain. Our results indi-
cate for the first time that exercise can protect against
METH-induced oxidation stress in brain capillaries and dis-
ruption of the BBB by enhancing the antioxidant protection
of brain microvessels. Overall, this study strongly suggests
that exercise may protect against cerebrovascular toxicity of
drugs of abuse, such as METH.
Results
Voluntary wheel running as a model of endurance
exercise in mice
A typical running pattern over a 5-week wheel running
is shown in Figure 1A. As indicated, mice required one
week adaptation period to the running wheel and then
maintained the running activity for the duration of the
study, running on average 12 to 14 km per 24 h. The
mice used the running wheels regularly and ran on aver-
age for 10.3 ± 0.33 h/day. Figure 1B is a histogram illus-
trating individual running behavior of 16 mice that have
been used in the present study. The average speed of
running over a 5 week period is plotted for each mouse.
The average speed for all mice was 1.12 km/h and is
marked as a vertical line. Variability in the running speed
ranged from 0.81 - 1.5 km/h. Endurance training employed
in our study slightly decreased the body weight of studied
mice (30.9 ± 0.41 g for sedentary mice vs. 28.4 ± 0.3 g for
exercised mice).
Exercise protects against METH-induced oxidative
reactions in brain capillaries
In the first series of experiments, we determined oxida-
tive stress by DHE staining in brain capillaries from
Figure 1 Characterization of the voluntary wheel running. (A) Typical running pattern of a mouse subjected to voluntary wheel running. The
arrow indicates the end of a one week adaptation process to adjust to running behavior and solitary environment. (B) Average speed (km/h) for
individual mice used in the present study.
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exercised and sedentary mice exposed to METH
(10 mg/kg, i.p.) or saline (vehicle control) for 24 h. As
indicated in Figure 2, METH exposure in sedentary mice
resulted in a striking increase in DHE fluorescence; how-
ever, this effect was completely abolished in exercised
mice.
We next focused on potential mechanisms of METH-
induced superoxide radical production in brain capillaries.
Recent evidence indicates that NAD (P)H oxidase (NOX) is
the primary prooxidative enzyme in vascular tissue. There-
fore, we evaluated the effects of METH on expression of
regulatory NOX subunits, such as p47 and gp91. Exposure
of sedentary mice to METH resulted in increased phosphor-
ylation of p47 (Figure 3A) and increased expression of gp91
(Figure 3B). Importantly, exercise attenuated these effects.
In addition, METH treatment stimulated phosphorylation of
66Shc, a potent prooxidative enzyme localized in mitochon-
dria (Figure 3C).
Exercise stimulates antioxidative protection in brain
capillaries
Oxidative stress is frequently associated with changes in
antioxidant levels. Therefore, we assessed the tissue
levels of glutathione in exercised and sedentary mice ex-
posed to METH. As shown in Figure 4A, exposure to
METH for 3 h resulted in decreased glutathione levels
in brain capillaries in sedentary animals. Exercise slightly
increased the baseline levels of glutathione in brain ca-
pillaries. In addition, exercise prevented the METH-
induced alterations of glutathione levels.
Activation of transcription factor Nrf-2 can provide
another compensatory mechanism to protect tissues
from increased oxidative stress by inducing expression
of antioxidative enzymes. Figure 4B indicates that treat-
ment with METH increased Nrf-2 phosphorylation in
brain capillaries. Importantly, the expression of phos-
phorylated Nrf-2 was even more pronounced in brain
capillaries of exercised mice exposed to METH as com-
pared to METH-treated sedentary animals, further dem-
onstrating the protective effects of exercise against
METH-induced tissue oxidative reactions.
Exercise protects against METH-induced disruption and
redistribution of TJ proteins
Intact TJs are the critical elements that regulate integrity
and the barrier function of the brain endothelium. Dis-
ruption of TJs promotes neuroinflammatory responses
by allowing paracellular entry of inflammatory cells into
the brain. Therefore, we evaluated the effects of METH
and/or exercise on TJ protein expression in brain micro-
vasculature 24 h post METH treatment (Figure 5A and
5B). We focused on integrity and co-localization of TJ
proteins as detected by immunofluorescence as they fre-
quently define a proper function of the cerebral vascula-
ture. Isolated brain capillaries were stained for
transmembrane TJ proteins, occludin and claudin-5, and
for TJ accessory protein ZO-1. In sedentary controls,
occludin and ZO-1 staining revealed characteristic linear
immunoreactivity consistent with TJ areas at the borders
of adjacent endothelial cells. METH exposure in seden-
tary mice resulted in dramatic changes in occludin
Figure 2 Exercise protects against METH-induced oxidative stress in brain capillaries. Mice were subjected to voluntary wheel running for
5 weeks. Control (i.e., sedentary) mice did not have access to wheels. At the end of the exercise regimen, mice were injected with METH (10 mg/
kg, i.p.) for 24 h. Superoxide levels were determined in isolated brain capillaries by dihydroethidine (DHE). The images are representative data
from three independent experiments and the quantified results (mean ± SEM) are depicted in the form of bar graphs. ***As compared to the
respective controls at p < 0.001. †††Data in the exercised group are significantly different as compared to the respective treatment in the
sedentary group at p < 0.001.
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immunoreactivity that shifted from the TJ areas into
endothelial cell cytoplasm (arrows in Figure 5A, the top
row). Changes in occludin staining were accompanied by
a decrease and fragmentation of ZO-1 immunoreactivity
in METH-exposed sedentary mice (arrows in Figure 5A,
middle row). As the result, occludin and ZO-1
colocalization pattern was markedly altered as illustrated
in merged images that were additionally combined with
Nomarski interference contrast technique to visualize
the capillaries (Figure 5A, bottom row). In addition to
changes in occludin and ZO-1, exposure to METH in
sedentary mice resulted in decreased and fragmented
immunoreactivity of claudin-5 in brain capillary (arrows
in Figure 5B). However, exercise effectively attenuated
these changes.
Published data reported that METH treatment can di-
minish TJ protein expression even at early exposure time
in brain endothelial cells. This possibility was also tested
in our present study. Mice were injected with METH
(10 mg/kg) for 1 h, followed by estimation of occludin
levels in brain capillaries. Figure 5C illustrates that such
a short exposure to METH was sufficient to significantly
decrease occludin level.
Exercise attenuates METH-induced disruption of the BBB
integrity
Disruption of the BBB may be the ultimate outcome of
METH cerebrovascular toxicity. Indeed, alterations of the
BBB integrity are directly involved in trafficking of inflam-
matory cells into the brain and in the development of
neuroinflammatory responses. Therefore, we analyzed the
effects of METH and exercise on permeability across the
BBB in discrete brain regions. As shown in Figure 6, BBB in-
tegrity in sedentary mice was significantly disrupted 1 h post
Figure 3 Exercise attenuates METH-induced up regulation of prooxidative enzymes. Mice were exercised and exposed to METH as
described in the legend to Figure 2. Regulatory subunits of NOX, such as phosphorylated-p47 (A; p-p47) and gp91 (B), as well as phosphorylated
mitochondrial protein 66Shc (p66Shc) (C) were determined by immunoblotting. Levels of p-47 and gp61 were normalized to β-actin and levels of
p66Shc were normalized to total 66Shs. The blots are representative data from three independent experiments and the quantified results (mean
± SEM) are depicted in the form of bar graphs. *As compared to the respective controls at **p < 0.01 or ***p < 0.001. †Data in the exercised
group are significantly different as compared to the respective treatment in the sedentary group at ††p < 0.01 or †††p < 0.001.
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METH administration, consistent with occludin expression
changes, which occurred at the same time point. The most
sensitive brain regions to METH toxicity were the cortex
and the hippocampus. Importantly, exercise markedly atten-
uated BBB hyper permeability induced by METH in all
brain regions in exercised mice. Treatment with METH
(10 mg/kg) for 12 or 24 h did not result in functional
changes of BBB integrity (data not shown).
Discussion
Behavioral factors, such as physical activity, may influ-
ence substance abuse and toxicity. Exercise has been
shown to activate brain reward pathways [17]; thus, it
may regulate the initiation of drug abuse and modulate
the development of addiction [18]. For example, studies
on tobacco cessation indicated that exercise can effect-
ively control cigarette cravings [19]. It was also reported
that METH exposure can decrease proliferation and sur-
vival of medial prefrontal cortex precursors and that ex-
ercise protected against this effect [20]. However, the
effects of exercise on cerebrovascular toxicity of drugs of
abuse, including METH, are unknown. In the present
study, we propose that enhanced antioxidant capacity of
cerebral capillaries by exercise is the main mechanism
responsible for exercise-mediated protection against
METH-induced cerebrovascular toxicity. To address this
hypothesis, we employed voluntary wheel running sys-
tem that is an established model of endurance exercise
for mice. The model is based on a computerized wheel
cage system, allowing the mice to voluntarily run to
more closely mimic human behavior. Taking into con-
sideration the CNS effects of METH, we specifically fo-
cused our study on the BBB.
Evidence indicates that induction of oxidative stress
may contribute to METH toxicity [7-10,12]. This mech-
anism may have particular significance in the CNS, be-
cause reactive oxygen species (ROS) are generated
continuously in the brain during normal metabolism
and neuronal activity to meet the high energy demand
of the brain. The brain is highly sensitive to any imbal-
ance in ROS due to it its high oxygen consumption, high
iron and lipid contents, and low activity for antioxidant
defences. Likewise, ROS disequilibrium in the brain is
associated with several CNS disease states [21]. Our
Figure 4 Exercise induces antioxidant protection in brain capillaries of METH-exposed mice. Mice were exercised and exposed to METH as
described in the legend to Figure 2. (A) Glutathione levels were determined in isolated brain capillaries by staining with monochlorobimane
(MCB). The images (left panel) are representative data from three independent experiments and the quantified results (mean ± SEM) are depicted
in the form of the bar graph (right panel). (B) The expression of phosphorylated Nrf-2 (p-Nrf-2) was determined in brain capillaries by
immunoblotting and normalized to β-actin level. The blots are representative data from three independent experiments and the quantified
results (mean ± SEM) are depicted in the form of bar graphs. *As compared to the respective controls at *p < 0.05 or ***p < 0.001. †Data in the
exercised group are significantly different as compared to the respective treatment in the sedentary group at ††p < 0.01 or †††p < 0.001.
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present data demonstrate that treatment with METH in-
duced oxidative stress at the level of brain capillaries.
DHE staining used in these analyses specifically indicates
the prominent increase in superoxide radicals in brain
capillaries of mice injected with METH. These results
on METH-induced tissue oxidation in brain microvascu-
lature are consistent with literature reports indicating
stimulation of oxidative stress in brain endothelial cells
upon METH exposure [9,10,12,22]. Increased levels of
lipid per oxidation products were also demonstrated in
chronic users of METH [22-24]. The role of oxidative
stress in METH-induced toxicity is further supported by
the observations that administration of antioxidants can
attenuate METH-induced cellular toxicity. In addition,
mice overexpressing copper-zinc or manganese super-
oxide dismutase (CuZnSOD or MnSOD, respectively)
are protected against neurotoxicity of METH [25].
Several mechanisms, including autoxidation of dopa-
mine and 6-hydroxydopamine and/or autoxidation of
serotonin, may be responsible for METH-induced oxida-
tion [26]. However, these factors are unlikely to play a
major role in METH-induced oxidation in cells or tis-
sues that lack dopaminergic or serotonergic innerva-
tions. Our recent data indicated the METH-induced
activation of NOX is an important source of ROS in
brain endothelial cells. Indeed, inhibition of NOX by
NSC 23766 attenuated METH-induced ROS generation,
an effect associated with protection against changes in
occludin expression, and transendothelial monocyte mi-
gration [10]. The results of the present study indicate
that treatment with METH can induce phosphorylation
of p47 and expression levels of gp91, both being the
regulatory subunits of NOX. The importance of these
findings rely on the fact that phosphorylation of p47
Figure 5 Exercise protects against METH-induced fragmentation and redistribution of TJ proteins in brain capillaries. (A and B) Mice
were subjected to exercise and/or METH exposure as described in the legend to Figure 2. Top row illustrates occludin immunoreactivity, followed
by ZO-1, and merged images of occludin and ZO-1 (combined with the Nomarski technique to visualize capillaries). The bottom row illustrated
claudin-5 immunoreactivity. In sedentary mice, METH exposure resulted in redistribution of occludin and decreased expression and fragmentation
of ZO-1 and claudin-5 (arrows). These effects were markedly attenuated in exercised mice exposed to METH. (C) Mice were administered with
METH (10 mg/kg, i.p.) for 1 h and occludin was assessed in isolated microvessels by immunoblotting. Data are mean ± SEM, n = 4. **As compared
to the respective controls at p < 0.01.
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stimulates its translocation into cell membranes and
interaction with other subunits, such as gp91 to assem-
bly of active NOX. An active NOX can induce oxidative
stress cascade by generation of superoxide due to one
electron transfer from NADH or NADPH [27]. Further-
more, our study indicated that METH treatment can in-
crease the levels of p66Shc, a redox enzyme that
generates reactive oxygen species in mitochondria via
subtraction of electrons from the mitochondrial electron
transport chain to catalyze the partial reduction of mo-
lecular oxygen [28,29].
The effects of exercise on the induction of antioxidative
enzymes and protection against lipoprotein oxidation are
well recognized [14-16]. Novel results of the present study
indicate that exercise can provide remarkable antioxidative
protection at the level of brain capillaries. We focused on
the effects of exercise and/or METH on capillary glutathione
because our previous studies determined that glutathione
levels are an excellent indicator of oxidative stress in endo-
thelial cells [30]. The quantitative and qualitative results of
MCB staining indicate that an acute METH exposure results
in a decrease in glutathione levels in brain capillaries. These
results are in agreement with earlier data that glutathione is
susceptible to METH treatment, as its levels are diminished
in METH abusers [23]. While exercise did not alter the
baseline levels of glutathione, it markedly protected against
METH-induced a decrease in glutathione levels in brain
capillaries.
We also evaluated the effects of METH and/or exercise
on phosphorylation of Nrf-2, a transcription factor that acti-
vates antioxidant responses. Normally, Nrf-2 is repressed in
cytoplasm by a protein called Kelch-like erythroid CNC
homologue (ECH)-associated protein 1 (Keap1). Nrf-2 is ac-
tivated and translocates into the nuclei upon phosphoryl-
ation mediated by several kinases, including those of the Ras
pathway [31]. The Ras cascade is regulated by cellular redox
status; thus, stimulation of Nrf-2 is consistent with METH
being a prooxidative factors. Nevertheless, activation of
Nrf-2 provides a mechanism of antioxidative protection by
binding to the antioxidant response elements (ARE), which
are present in the promoter regions of several antioxidative
enzymes, including MnSOD [32]. An increase in phosphor-
ylation of Nrf-2 by exercise is consistent with antioxidative
effects of physical activity.
Intercellular junctions are involved in the regulation of
integrity of the brain endothelium and the BBB func-
tions [33-35]. TJs allow for very close contact between
adjacent endothelial cells. In addition, cytosolic proteins,
e.g., ZO-1 (zonula occludens-1) and ZO-2 are associated
with the cytoplasmic surface of TJs. These proteins serve
as recognition proteins for TJ placement and act as sup-
port structures for signaling proteins. Occludin contrib-
utes to the electrical barrier, fence and signaling
functions of TJs [33-35]. Occludin is also a target to
METH-induced changes in endothelial barrier function.
Importantly, a METH-induced decrease in occludin
levels is an early event, occurring within 1 h following
METH treatment as demonstrated in both cultured
brain endothelial cells [10] and brain capillaries in the
current manuscript. Such a rapid response may explain
early changes in BBB permeability, which were also ob-
served in the present study. On the other hand, changes
in body temperature, which occur following METH
exposure, have also been linked to increased BBB
Figure 6 Exercise-mediated protection against METH-induced disruption of the BBB. Mice were exercised as described in Figure 2 and
exposed to METH (10 mg/kg) for 1 h. The BBB integrity was evaluated by i.p. injecting 100 μl 2% sodium fluorescein (NaF). Fifteen minutes post
NaF injection, permeability across the BBB was calculated in the discrete brain regions (hippocampus, cortex, and putament) as the ratio of
fluorescence in the brain tissue to plasma. The data are mean SEM, n = 5. *As compared to the respective controls at *p < 0.05, **p < 0.01,
or ***p < 0.001. †Data in the exercised group are significantly different as compared to the respective treatment in the sedentary group at
††p < 0.01 or †††p < 0.001.
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permeability [36]. Disruption of the BBB may directly
contribute to METH neurotoxicity and neuroinflammatory
responses by allowing blood-born inflammatory cells entry
into the brain. Therefore, it is important that exercise
prevented METH-induced BBB breakdown. In addition to
occludin, METH exposure decreased expression of claudin-
5, a TJ protein that was specifically linked to diminished
endothelial barrier function and disruption of the BBB [37].
In fact, knockout of claudin-5 resulted in a selective increase
in paracellular permeability of small molecules across the
BBB [38]. Thus, exercise-mediated protection against
changes in claudin-5 immunoreactivity provides another im-
portant mechanism of protection against METH-induced al-
teration of the BBB integrity.
METH-induced changes in expression and immunore-
activity of TJ proteins may be caused by induction of
oxidative stress. For example, studies performed in our
and other laboratories demonstrated that oxidative stress
can alter the integrity of the BBB at the level of TJs act-
ing through Ras and/or Rho redox responsive signaling
[39-41]. These pathways were demonstrated to play im-
portant roles in the regulation of claudin-5, ZO-1, and
ZO-2 expression as well as the BBB assembly [39-43].
Other pathways that have been shown to affect TJ pro-
teins are also redox-responsive and include the MAP
kinase cascade, STAT1, and PI3 kinase.
Conclusions
Our results indicate that acute exposure to METH in-
duces profound oxidative stress and disruption of TJ
proteins in cerebral microvessels. Most importantly, en-
durance exercise training protects against these effects
and prevents METH-induced disruption of the BBB in-
tegrity. This data is important for a better understanding
of the molecular mechanisms underlying METH-related
cerebrovascular injury and indicates that exercise can
protect against the cerebrovascular component of
METH-induced neurotoxicity.
Materials and methods
Animals, experimental groups, and isolation of brain
capillaries
The study was performed on male C57BL/6 mice
(7–8 weeks old; weight 25–28 g, Harlan Laboratories,
Indianapolis, IN). C57BL/6 mice are prone to develop
addiction [17] and exert high running behavior. Mice
were divided into the exercise and sedentary groups.
The exercise group was subjected to voluntary running
in modified shoebox wheel cages (Coulbourn Instru-
ments, Whitehall, PA). The frequency, duration, and in-
tensity of each running session were monitored for each
mouse via a direct data link to a computer and the run-
ning data are analyzed by Clock lab and Mat lab soft-
ware (Actimetrics, Wilmette, IL, and Natick, MA,
respectively). Mice exercised for 5 weeks, including one
week of adaptation period during which mice adjusted
to solitary living and running wheel. The sedentary
(control) group of mice did not have access to running
wheels. At the end of 5 weeks exercise period, both
the exercised and sedentary mice were injected i.p.
either with a single dose of METH (10 mg/kg as
D-methamphetamine hydrochloride; Sigma) or with ve-
hicle (saline). An acute exposure to one dose of METH
is relevant to individuals who initiate METH abuse,
which occur frequently in young age. A single dose of
METH was shown to increase attention, concentration,
and psychomotor performance, which may result in de-
veloping the drug dependency [44]. The dose of METH
used in this study was consistent with doses used by
abusers who may use this drug in the amounts as high
as 1 g/day [45].
The majority of the experiments were terminated and
the animals were perfused with saline 24 h post METH
injection. The BBB is formed at the level of cerebral
microvessels; therefore, brain capillaries were used as
the main experimental material in this study. Capillary-
enriched fraction was isolated from brains as described
earlier [46]. Briefly, mice were euthanized; brains were
removed and immediately immersed in ice-cold isolation
buffer. Choroid plexus, meninges, cerebellum, and brain
stem were removed, and brains were homogenized.
Then, 26% dextran was added, and samples were
centrifuged (5800 g; 4 C) for 10 min. The supernatants
were discarded; pellets were resuspended and filtered
through a 70 μm mesh filter. Filtered homogenates were
re-pelleted by centrifugation (1500 g; 10 min) and either
smeared on slides for confocal analysis or resuspended
in lysis buffer for analysis of protein expression.
Oxidative stress and glutathione detection
Oxidative stress and intracellular glutathione were
detected in brain capillaries using specific fluorescent
probes. The main advantages of such an experimental
approach are high sensitivity and specificity as well as
minimal interference during sample preparation. Freshly
isolated “intact” brain microvessels were smeared on
glass microscope slides and air-dried before staining.
Staining with dihydroethidium (DHE; Molecular Probes/
Life Technologies, Grand Island, NY) was used as the in-
dicator of oxidative stress. DHE is membrane permeable
and, in the presence of superoxide, is converted to the
fluorescent product ethidium bromide, which is trapped
by intercalating with DNA [47]. DHE (10 μM in DMSO)
was directly applied to brain microvessels and incubated
in a light-protected and humidified chamber at 37°C for
90 min. Images were acquired by confocal microscopy.
Monochlorobimane (MCB; Molecular Probes/Life
Technologies) was used as a probe for glutathione
Toborek et al. Molecular Neurodegeneration 2013, 8:22 Page 8 of 11
http://www.molecularneurodegeneration.com/content/8/1/22
(GSH) detection. The reaction is based on conjugation
of reduced glutathione with MCB [48] with normally
nonfluorescent MCB in a reaction catalyzed by glutathi-
one S-transferase. Isolated microvessels were incubated
with 100 μM MCB for 90 min at 37°C in cell culture in-
cubator. GSH-MCB fluorescence was detected using a
confocal microscope.
Assessment of tight junction (TJ) proteins
Freshly isolated intact microvessels were spread onto
glass microscope slides and heat fixed for 10 min at
95°C. Slides were washed with PBS and fixed in 4% for-
maldehyde for 10 min at 25°C. Slides were then re-
washed with PBS, permeabilized in 0.1% Triton X-100
for 5 min, washed in PBS containing 1% bovine serum
albumin (BSA) and then blocked in 1% BSA in PBS for
30 min at 25°C. Slides were incubated overnight at 37°C
with appropriate primary antibody (anti-occludin, anti-
ZO-1, or anti-claudin-5; all diluted 1:500 in 1% BSA in
PBS). The following day, slides were rinsed in 1% BSA
and re-blocked with 1% BSA for 30 min. Slides were
then incubated with either AlexaFluor 488-conjugated or
546-conjugated IgG (R&D Systems; Minneapolis, MN) for
1 h at 37°C. All slides were washed and mounted with
ProLong Gold Antifade reagent (Invitrogen/Life Tech-
nologies, Grand Island, NY) containing 4′,6-diamidino-2-
phenylindole (DAPI) to visualize the nuclei. Images were
acquired using an Olympus BX61WI (Olympus, Center
Valley, PA) laser scanning confocal microscope. Acquisi-
tion settings for AlexaFlour 488 (excitation at 488 nm and
detection range 500–535 nm) and AlexaFlour 546 (excita-
tion 546 nm and detection range 580–620 nm) were visu-
alized as green or red colored fluorescence, respectively.
Data were analyzed by Fluoview v. 5 image software
(Olympus). Images collected from the treatment and con-
trol groups were stained in parallel and collected under
uniform instrument setting. Slides prepared in the absence
of primary antibody resulted in a loss of specific
immunoreactivity.
Immunoblotting
Lysates of brain microvessels (30 μg protein/lane) were
resolved on 10-15% Tris–HCl gels (BioRad) for 60 min
at 120 V. The gels were then transferred to 0.45 μm
PVDF membranes (Perkin Elmer, Waltham, MA) at 6 V
for 20 min and 200 mAmp for 2 h, while immersed in a
10% methanol Tris-glycine (USB, Cleveland, OH) trans-
fer buffer. Membranes were blocked for 1.5 h at 25°C in
Superblock blocking buffer (Pierce/Thermo Scientific,
Rockford, IL) supplemented with 0.05% Tween 20 before
being incubated overnight at 4°C with respective primary
antibody diluted in fresh Superblock buffer. Membranes
were washed 3 times for 10 min with Tris base saline
supplemented with 0.05% Tween 20 (TBST) prior to 2 h
incubation with respective secondary antibody diluted in
Superblock buffer with 0.05% Tween 20 (1:1,000 for
anti-mouse IgG and 1:3,000 for anti-rabbit IgG). Mem-
branes were then re-washed in TBST, developed, and
the proteins of interest were detected using the ECL Plus
Western blotting detection system (Amersham, Piscataway,
NJ). Semi-quantification of protein was performed with
NIH Image J software and actin expression was used to
normalize the expression results.
BBB permeability assay
BBB permeability was assessed as described earlier with
slight modifications [49]. Mice were injected intraperito-
neally (i.p.) with sodium fluorescein (2% in 200 μl PBS)
which was allowed to circulate for 30 min. The animals
were anesthetized with isofluorane in oxygen, blood was
collected via heart puncture, and the mice were perfused
with heparinized saline. The brains were harvested and
the brain regions (hippocampus, frontal cortex, and puta-
men) were isolated, immediately immersed in liquid nitro-
gen and stored at −80°C. The regions were homogenized
in PBS (1:10 g/v) followed by protein measurement. The
samples were then precipitated in 10% trichloroacetic acid
(1:1 v/v) and centrifuged at 1000 g for 10 min. The pH
was adjusted by adding 8.33 μl 5 M NaOH to 100 μl
supernatant aliquots and fluorescence was detected using
a fluorescence plate reader with excitation at 485 nm and
emission at 530 nm. BBB permeability was expressed as
pg sodium fluorescein/μg protein.
Statistical analysis
Two-way ANOVA, followed by Student-Newman-Keuls
post hoc test or two-tailed Student’s t-test, was used to
compare mean responses among the treatments. A stat-
istical probability of p < 0.05 was considered significant.
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